IBYME   02675
INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Progesterone effects on transcription factors that drive oligodendrogenesis after spinal cord injury.
Autor/es:
JURE, I; GONZÁLEZ SL; DE NICOLA, A; LABOMBARDA, F
Lugar:
Huerta Grande
Reunión:
Congreso; XXIX Congreso anual de la Sociedad Argentina de Investigación en Neurociencias (SAN); 2014
Resumen:
After spinal cord injury, primary mechanical insult is
followed by the activation of a secondary cascade of events that ultimately
causes progressive degeneration of the neural tissue and demyelination. In
previous publications we have shown that progesterone acts as a remyelinating
agent favoring oligodendrocytes precursor cells differentiation. In this work,
we analyzed the effects of progesterone on the expression of the transcription
factors that drives remyelination after spinal cord injury. Our results shown that
3 days after injury, progesterone administration enhanced RNAm expression of the
pro differentiating factors, Mash 1, Sox 10, Nkx2.2 and Olig 2. Progesterone
also increased the number of oligodendrocytes precursor cells which expressed
Olig 2. Twenty one days after lesion,
progesterone increased the expression of the pro myelinating factor, Olig 1,
and reduced the expression of the inhibitors Id-2 and Hes-5. These results
suggest that short time of progesterone treatment might enhance oligodendrocytes
precursor cells differentiation by increasing stimulating transcription factors.
Long time of progesterone treatment might stimulate myelination by increasing the
expression of myelinating factors and by reducing the expression of inhibitors
of myelination. Progesterone could be a promising therapeutic agent for
patients with spinal cord injury and it also could be use as a treatment for demyelinated
diseases